Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Scaling down customs duty of medical devices in Union budget to increase healthcare affordability, says MTal

      Scaling down customs duty of medical devices in Union budget to increase healthcare affordability, says MTal

      Medical Dialogues Bureau10 July 2019 9:15 AM IST
      The increase in the turnover limit to INR 400 Crore under the 25 per cent tax slab is in line with the government's commitment in the Union budget...
      Trump administration drug officials clash over how to combat fentanyl copycats

      Trump administration drug officials clash over how to combat fentanyl copycats

      Medical Dialogues Bureau10 July 2019 9:00 AM IST
      WASHINGTON: Trump administration officials are divided over part of a proposal to crack down on illicit versions of fentanyl, the deadly synthetic...
      Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

      Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

      Medical Dialogues Bureau9 July 2019 12:49 PM IST
      Mumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...
      USFDA approves Glenmark Pharma anti-anginal drug Ranolazine ER Tablets

      USFDA approves Glenmark Pharma anti-anginal drug Ranolazine ER Tablets

      Medical Dialogues Bureau9 July 2019 9:45 AM IST
      The approved product is a generic version of Ranexa 1 Extended-Release Tablets, 500 mg and 1,000 mg, of Gilead Sciences, Inc.MUMBAI: Glenmark...
      Bayer seeks approval for blockbuster Xarelto to treat thromboembolism in children

      Bayer seeks approval for blockbuster Xarelto to treat thromboembolism in children

      Medical Dialogues Bureau9 July 2019 9:30 AM IST
      Bayer added that it would submit an application to the European Medicines Agency for an extension of the Xarelto marketing authorisation. It did not...
      UK hopes to prevent 100000 cancer cases; HPV vaccines will be rolled out to boys

      UK hopes to prevent 100000 cancer cases; HPV vaccines will be rolled out to boys

      Medical Dialogues Bureau9 July 2019 9:15 AM IST
      Announcing the extension of a vaccination programme to cover boys as well as girls, experts at Public Health England (PHE), said the immunisation plan...
      Oklahoma judge denies motion to end case against drugmaker JnJ

      Oklahoma judge denies motion to end case against drugmaker JnJ

      Medical Dialogues Bureau9 July 2019 9:00 AM IST
      District Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
      Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

      Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

      Medical Dialogues Bureau8 July 2019 1:32 PM IST
      As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
      Solara Cuddalore facility successfully completes USFDA inspection

      Solara Cuddalore facility successfully completes USFDA inspection

      Medical Dialogues Bureau8 July 2019 9:35 AM IST
      Chennai: Solara Active Pharma Science Limited (Solara), an Active Pharmaceutical Ingredient(API) provider recently announced the successful completion...
      City council reviews use of Bayer Roundup weed killer amid cancer fears

      City council reviews use of Bayer Roundup weed killer amid cancer fears

      Medical Dialogues Bureau8 July 2019 9:15 AM IST
      Bayer says Roundup is safe and backed by several regulatory bodies, despite research that found its main ingredient glyphosate was probably...
      Trump promises to reduce prescription drug prices to lowest

      Trump promises to reduce prescription drug prices to lowest

      Medical Dialogues Bureau8 July 2019 9:00 AM IST
      Despite pressure from the president, US pharmaceutical giant Pfizer in January increased the price of 41 drugs, which represents 10 per cent of its...
      Karyopharm Therapeutics gets USFDA nod for blood cancer drug Xpovio

      Karyopharm Therapeutics gets USFDA nod for blood cancer drug Xpovio

      Medical Dialogues Bureau7 July 2019 9:45 AM IST
      The drug Xpovio was approved in combination with dexamethasone for patients who have received at least four prior therapies and who fail to respond to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok